Verfügbarkeit: Autoantibodies in organ specific autoimmune diseases

Autoantibodies in organ specific autoimmune diseases: a diagnostic reference

Gespeichert in:

Bibliographische Detailangaben
Beteiligte Personen:	Conrad, Karsten 1956- (VerfasserIn), Schößler, Werner (VerfasserIn), Hiepe, Falk (VerfasserIn), Fritzler, Marvin J. (VerfasserIn)
Format:	Buch
Sprache:	Deutsch
Veröffentlicht:	Lengerich ; Berlin ; Bremen ; Miami ; Riga ; Viernheim ; Wien ; Zagreb Pabst Science Publishers 2017
Ausgabe:	second edition
Schriftenreihe:	Autoantigens, autoantibodies, autoimmunity Volume 8
Schlagwörter:	Autoaggressionskrankheit Serodiagnostik Autoantikörper Wörterbuch
Links:	http://digitale-objekte.hbz-nrw.de/storage2/2018/03/05/file_19/7577842.pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030515413&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
Umfang:	XVI, 348 Seiten Illustrationen
ISBN:	9783958533486

Internformat

MARC


LEADER	00000nam a2200000 cb4500
001	BV045125307
003	DE-604
005	20181015
007	t\|
008	180808s2017 xx a\|\|\| \|\|\|\| 00\|\|\| ger d
016	7		\|a 1144662133 \|2 DE-101
020			\|a 9783958533486 \|c Broschur \|9 978-3-95853-348-6
035			\|a (OCoLC)1043879941
035			\|a (DE-599)DNB1144662133
040			\|a DE-604 \|b ger \|e rda
041	0		\|a ger
049			\|a DE-578 \|a DE-19 \|a DE-355 \|a DE-91
084			\|a XG 4414 \|0 (DE-625)152802:12920 \|2 rvk
084			\|a WD 301 \|2 nlm
084			\|a MED 330f \|2 stub
100	1		\|a Conrad, Karsten \|d 1956- \|e Verfasser \|0 (DE-588)110452917 \|4 aut
245	1	0	\|a Autoantibodies in organ specific autoimmune diseases \|b a diagnostic reference \|c Karsten Conrad, Werner Schößler, Falk Hiepe, Marvin J. Fritzler
250			\|a second edition
264		1	\|a Lengerich ; Berlin ; Bremen ; Miami ; Riga ; Viernheim ; Wien ; Zagreb \|b Pabst Science Publishers \|c 2017
300			\|a XVI, 348 Seiten \|b Illustrationen
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	1		\|a Autoantigens, autoantibodies, autoimmunity \|v Volume 8
650	0	7	\|a Autoaggressionskrankheit \|0 (DE-588)4003935-3 \|2 gnd \|9 rswk-swf
650	0	7	\|a Serodiagnostik \|0 (DE-588)4181044-2 \|2 gnd \|9 rswk-swf
650	0	7	\|a Autoantikörper \|0 (DE-588)4215429-7 \|2 gnd \|9 rswk-swf
655		7	\|0 (DE-588)4066724-8 \|a Wörterbuch \|2 gnd-content
689	0	0	\|a Autoaggressionskrankheit \|0 (DE-588)4003935-3 \|D s
689	0	1	\|a Serodiagnostik \|0 (DE-588)4181044-2 \|D s
689	0	2	\|a Autoantikörper \|0 (DE-588)4215429-7 \|D s
689	0		\|5 DE-604
700	1		\|a Schößler, Werner \|e Verfasser \|0 (DE-588)1165012626 \|4 aut
700	1		\|a Hiepe, Falk \|e Verfasser \|0 (DE-588)109617266 \|4 aut
700	1		\|a Fritzler, Marvin J. \|e Verfasser \|0 (DE-588)1165020831 \|4 aut
710	2		\|a Gesellschaft zur Förderung der Immundiagnostik \|e Sonstige \|0 (DE-588)10091100-6 \|4 oth
776	0	8	\|i Erscheint auch als \|n Online-Ausgabe, eBook \|z 978-3-95853-349-3
830		0	\|a Autoantigens, autoantibodies, autoimmunity \|v Volume 8 \|w (DE-604)BV014013293 \|9 8
856	4	2	\|m B:DE-101 \|q application/pdf \|u http://digitale-objekte.hbz-nrw.de/storage2/2018/03/05/file_19/7577842.pdf \|3 Inhaltsverzeichnis
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030515413&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
943	1		\|a oai:aleph.bib-bvb.de:BVB01-030515413

Datensatz im Suchindex

DE-BY-TUM_call_number	1102 MED 330f 2018 A 4647(2)
DE-BY-TUM_katkey	2367941
DE-BY-TUM_location	11
DE-BY-TUM_media_number	040009187259
_version_	1821934328052973568
adam_text	CONTENTS PREFACE OF THE 2ND EDITION XVII PREFACE OF THE 1ST EDITION XVIII NOTES ON THE USE OF THIS BOOK 1 INTRODUCTION 2 AUTOANTIBODIES - DEFINITIONS AND CHARACTERISTICS 2 AUTOANTIBODIES IN THE DIAGNOSIS OF AUTOIMMUNE DISEASES 2 P A R TI A U TO A N TIB O D IE S IN ORGAN S P E C IFIC AU TO IM M U NE DISEASES 17A-HYDROXYLASE ANTIBODIES...................................................................................................... 6 21-HYDROXYLASE ANTIBODIES........................................................................................................ 6 AADC ANTIBODIES.......................................................................................................................6 ACETYLCHOLINE RECEPTOR ANTIBODIES, CLASSICAL TYPE..................................................................... 6 ACETYLCHOLINE RECEPTOR ANTIBODIES, GENERAL .............................................................................. 8 ACTIN ANTIBODIES.........................................................................................................................9 ADAMTS13 ANTIBODIES........................................................................................................... 11 ADENYLATE KINASE 5 ANTIBODIES................................................................................................ 11 ADRENAL CORTEX ANTIBODIES....................................................................................................... 12 ADRENOCEPTOR ANTIBODIES..........................................................................................................14 ALPHA ENOLASE ANTIBODIES........................................................................................................ 15 ALVEOLAR BASEMENT MEMBRANE ANTIBODIES...............................................................................16 AMA (ANTI-MITOCHONDRIAL ANTIBODIES)......................................................................................16 AMA-M2................................................................................................................................... 18 AMA-M4...................................................................................................................................21 AMA-M8...................................................................................................................................22 AMA-M9...................................................................................................................................23 AMPA RECEPTOR ANTIBODIES....................................................................................................... 24 AMPHIPHYSIN ANTIBODIES.......................................................................................................... 25 AMYLASE ALPHA-2A ANTIBODIES.................................................................................................27 ANGIOTENSIN 1 RECEPTOR (AT 1R) ANTIBODIES ............................................................................. 27 ANNA-1.................................................................................................................................... 29 ANNA-2.................................................................................................................................... 29 ANNA-3.....................................................................................................................................29 ANTI-MITOCHONDRIAL ANTIBODIES...................................................................................................30 ANTI-NEURONAL NUCLEAR ANTIBODIES (ANNA)...............................................................................31 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) ................................................................... 31 ANTI-NUCLEAR ANTIBODIES (ANA) ................................................................................................ 31 ANTI -SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA)..................................................................33 AP3B2 ANTIBODIES.................................................................................................................... 34 APOLIPROTEIN A-1 ANTIBODIES......................................................................................................35 AQUAPORIN 4 ANTIBODIES............................................................................................................37 ARHGAP ANTIBODIES................................................................................................................ 38 AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) ANTIBODIES ..................................................... 39 ASGPR ANTIBODIES...................................................................................................................40 ATP1 A3 ANTIBODIES..................................................................................................................41 ATYPICAL ANCA......................................................................................................................... 42 BASAL GANGLIA ANTIBODIES (ABGA)........................................................................................... 42 BETA 1 ADRENERGIC RECEPTOR ANTIBODIES.................................................................................... 45 BETA 2 ADRENERGIC RECEPTOR ANTIBODIES.................................................................................... 46 BITHERMAL HEMOLYSINS...............................................................................................................46 BP180 ANTIBODIES..................................................................................................................... 46 BP230 ANTIBODIES..................................................................................................................... 47 BPI ANTIBODIES.......................................................................................................................... 47 BPIFA1 ANTIBODIES................................................................................................................... 49 BPIFB1 ANTIBODIES................................................................................................................... 49 BSEP ANTIBODIES...................................................................................................................... 49 C1 INHIBITOR ANTIBODIES.............................................................................................................50 C1Q ANTIBODIES......................................................................................................................... 51 C3 NEPHRITIC FACTOR (C3NEF).....................................................................................................53 C4 NEPHRITIC FACTOR (C4NEF).....................................................................................................54 CALCIUM CHANNEL ANTIBODIES.....................................................................................................55 CALCIUM SENSITIVE RECEPTOR ANTIBODIES..................................................................................... 57 CAR ANTIBODIES........................................................................................................................ 58 CARBOANHYDRASE II ANTIBODIES................................................................................................. 58 CARP VIII ANTIBODIES............................................................................................................... 59 CASPR 1 ANTIBODIES................................................................................................................... 59 CASPR 2 ANTIBODIES................................................................................................................... 60 CHOLINERGIC RECEPTOR ANTIBODIES.............................................................................................. 61 COAGULATION FACTOR ANTIBODIES................................................................................................. 61 COLD ANTIBODIES........................................................................................................................ 62 COLLAGEN VII ANTIBODIES............................................................................................................62 COLONIC EPITHELIAL ANTIBODIES....................................................................................................62 COMPLEMENT ANTIBODIES...........................................................................................................63 CONTACTIN-1 ANTIBODIES............................................................................................................ 63 CORTACTIN ANTIBODIES................................................................................................................ 64 CRMP3-4 ANTIBODIES............................................................................................................... 64 CUZD1 ANTIBODIES.................................................................................................................. 64 CV2/CRMP5 ANTIBODIES..........................................................................................................65 CYP ANTIBODIES....................................................................................................................... 66 CYTOCHROME P450 ANTIBODIES..................................................................................................67 CYTOCHROME P450 SIDE CHAIN CLEAVAGE ENZYME (P450SCC) ANTIBODIES .............................. 68 CYTOKINE ANTIBODIES................................................................................................................ 68 DESMOGLEIN 1 ANTIBODIES........................................................................................................69 DESMOGLEIN 3 ANTIBODIES........................................................................................................70 DGP ANTIBODIES....................................................................................................................... 70 DIHYDROPYRIDINE RECEPTOR ANTIBODIES ...................................................................................... 70 DONATH-LANDSTEINER ANTIBODIES..............................................................................................71 DPPX ANTIBODIES.................................................................................................................... 71 ENDOMETRIAL ANTIBODIES........................................................................................................... 72 ENDOMYSIUM ANTIBODIES (EMA)..............................................................................................72 ENDOTHELIN 1 ETA RECEPTOR ANTIBODIES ................................................................................... 74 ENTEROCYTE ANTIBODIES............................................................................................................. 74 EPIDERMAL TRANGLUTAMINASE ANTIBODIES ................................................................................... 75 ER-10 ANTIBODIES.................................................................................................................... 75 ERYTHROCYTE ANTIBODIES............................................................................................................ 76 FACTOR VIII ANTIBODIES.............................................................................................................. 78 FACTOR B ANTIBODIES................................................................................................................. 80 FACTOR H ANTIBODIES................................................................................................................. 81 F CE RI ANTIBODIES..................................................................................................................... 81 FC RECEPTOR ANTIBODIES............................................................................................................ 82 FOLATE RECEPTOR ANTIBODIES......................................................................................................82 GABA A RECEPTOR ANTIBODIES.....................................................................................................82 GABAS RECEPTOR ANTIBODIES.....................................................................................................83 GAD ANTIBODIES....................................................................................................................... 84 GANGLIONIC NACHR ANTIBODIES.................................................................................................86 GANGLIOSIDE ANTIBODIES........................................................................................................... 87 GEPHYRIN ANTIBODIES................................................................................................................ 92 GLIADIN ANTIBODIES................................................................................................................... 92 GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODIES.............................................................94 GLUR3 ANTIBODIES.................................................................................................................... 96 GLUR-DELTA 2 ANTIBODIES.......................................................................................................... 97 GLUTAMATE RECEPTOR ANTIBODIES................................................................................................97 GLYCINE RECEPTOR (GLYR) ANTIBODIES.........................................................................................97 GLYCOLYTIC ENZYME ANTIBODIES.................................................................................................98 GLYCOPROTEIN 2 (GP2) ANTIBODIES............................................................................................. 99 GLYCOPROTEIN 210 (GP210) ANTIBODIES...................................................................................99 GM-CSF ANTIBODIES...............................................................................................................101 GOBLET CELL ANTIBODIES (GAB)................................................................................................ 102 GOR ANTIBODIES..................................................................................................................... 105 GWB ANTIBODIES..................................................................................................................... 106 HEART MUSCLE ANTIBODIES........................................................................................................107 HEAT SHOCK PROTEIN (HSR) ANTIBODIES.................................................................................... 108 HEXOKINASE-1 (HK1) ANTIBODIES............................................................................................ 109 H+/K+ ATPASE ANTIBODIES......................................................................................................109 HOMER-3 ANTIBODIES...............................................................................................................110 HORMONE ANTIBODIES...............................................................................................................110 HU ANTIBODIES (ANNA-1)....................................................................................................... I L L IA2 ANTIBODIES........................................................................................................................ 113 IGF-1 RECEPTOR ANTIBODIES......................................................................................................114 IGLONS ANTIBODIES................................................................................................................. 115 INSULIN ANTIBODIES...................................................................................................................116 INSULIN RECEPTOR ANTIBODIES.....................................................................................................117 INTERFERON ANTIBODIES..............................................................................................................118 INTRINSIC FACTOR ANTIBODIES (IFA)............................................................................................. 119 ISLET CELL ANTIBODIES (IGA).......................................................................................................120 ITPR1 ANTIBODIES...................................................................................................................122 KCNH2 ANTIBODIES................................................................................................................. 122 KELCH-LIKE (KLHL12) ANTIBODIES............................................................................................ 123 LAD-1 ANTIBODIES...................................................................................................................123 LAMIN ANTIBODIES....................................................................................................................123 LAMIN B RECEPTOR (LBR) ANTIBODIES....................................................................................... 124 LAMP-2 ANTIBODIES................................................................................................................126 LC1 ANTIBODIES....................................................................................................................... 127 LEYDIG CELL ANTIBODIES............................................................................................................129 LGI1 ANTIBODIES....................................................................................................................... 130 LKM1 ANTIBODIES.................................................................................................................... 130 LKM2 ANTIBODIES....................................................................................................................133 LKM3 ANTIBODIES.................................................................................................................... 133 LM ANTIBODIES........................................................................................................................ 134 LP/SLA ANTIBODIES.................................................................................................................135 LRP4 ANTIBODIES....................................................................................................................135 L-TYPE CALCIUM CHANNEL ANTIBODIES........................................................................................ 135 M2R ANTIBODIES...................................................................................................................... 136 M3R ANTIBODIES...................................................................................................................... 136 MAI ANTIBODIES...................................................................................................................... 136 MA2 ANTIBODIES..................................................................................................................... 137 MAG ANTIBODIES..................................................................................................................... 138 MARTI ANTIBODIES................................................................................................................ 139 MAHCR1 ANTIBODIES............................................................................................................. 140 MGLUR ANTIBODIES................................................................................................................. 140 MOESIN ANTIBODIES................................................................................................................. 141 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTIBODIES ...................................................................... 141 MUSK ANTIBODIES................................................................................................................... 142 MYOSIN ANTIBODIES................................................................................................................. 143 NALP5 ANTIBODIES................................................................................................................ 143 NEUROCHONDRIN ANTIBODIES..................................................................................................... 144 NEUROFASCIN ANTIBODIES......................................................................................................... 144 NEUTROPHIL ANTIBODIES............................................................................................................ 145 NEUTROPHIL SPECIFIC ANTIBODIES...............................................................................................146 NMDA RECEPTOR ANTIBODIES.................................................................................................... 147 NUCLEAR BODY ANTIBODIES....................................................................................................... 150 NUCLEAR ENVELOPE ANTIBODIES................................................................................................. 150 NUCLEOPORIN ANTIBODIES......................................................................................................... 151 N-TYPE CALCIUM CHANNEL ANTIBODIES.......................................................................................151 ONA ANTIBODIES..................................................................................................................... 152 OVARIAN ANTIBODIES................................................................................................................ 154 P62 ANTIBODIES...................................................................................................................... 154 P95C ANTIBODIES.................................................................................................................... 155 PANCA....................................................................................................................................155 PANCREAS ACINARANTIBODIES (PAB)..........................................................................................156 PANCREAS ANTIBODIES............................................................................................................. 157 PARANEOPLASTIC ANTIBODIES................................................................................................ 157 PARIETAL CELL ANTIBODIES (PCA)................................................................................................158 PBCNA ANTIBODIES................................................................................................................ 159 PEMPHIGOID ANTIBODIES......................................................................................................... 159 PEMPHIGUS ANTIBODIES.......................................................................................................... 162 PGSF1 A ANTIBODIES............................................................................................................... 164 PGSF2 ANTIBODIES................................................................................................................. 164 PIT-1 ANTIBODIES.................................................................................................................... 164 PITUITARY ANTIBODIES................................................................................................................ 165 PHOSPHOLIPASE A2 RECEPTOR ANTIBODIES.............................................. 165 PHOSPHOLIPID ANTIBODIES.......................................................................................................166 PKCY ANTIBODIES................................................................................................................... 168 PML ANTIBODIES..................................................................................................................... 168 POTASSIUM CHANNEL ANTIBODIES.......................................................................................... ...169 P/Q-TYPE CALCIUM CHANNEL ANTIBODIES...................................................................................171 PROTEINASE 3 ANTIBODIES........................................................................................................ 171 PURKINJE CELL ANTIBODIES..........................................................................................................171 PURKINJE CELL ANTIBODIES TYPE 2 (PCA-2).................................................................................172 RECEPTOR ANTIBODIES...............................................................................................................173 RECOVERIN ANTIBODIES.............................................................................................................174 RETICULIN ANTIBODIES...............................................................................................................174 RETINA ANTIBODIES...................................................................................................................175 RI ANTIBODIES.......................................................................................................................... 177 ROCK2 ANTIBODIES.................................................................................................................179 R052/TRIM21 ANTIBODIES...................................................................................................... 179 RYANODINE RECEPTOR ANTIBODIES............................................................................................. 180 SLA/LP ANTIBODIES.................................................................................................................181 SMA....................................................................................................................................... 183 SOX1 ANTIBODIES....................................................................................................................185 80X13 ANTIBODIES..................................................................................................................186 SP100 ANTIBODIES...................................................................................................................187 SPERMATOZOA ANTIBODIES....................................................................................................... 189 STEROID PRODUCING CELL ANTIBODIES......................................................................................... 190 SUMO ANTIBODIES..................................................................................................................192 THROMBOCYTE ANTIBODIES....................................................................................................... 193 THSD7A ANTIBODIES............................................................................................................194 THYROGLOBULIN ANTIBODIES....................................................................................................... 195 THYROPEROXIDASE ANTIBODIES.................................................................................................. 196 TISSUE TRANSGLUTAMINASE (TTG) ANTIBODIES............................................................................198 TITLN ANTIBODIES.....................................................................................................................201 TRANSGLUTAMINASE (TG) ANTIBODIES........................................................................................202 TRANSGLUTAMINASE 3 (TG3) ANTIBODIES..................................................................................202 TRANSGLUTAMINASE 6 (TG6) ANTIBODIES..................................................................................202 TR/DNER ANTIBODIES.............................................................................................................. 203 TRIB2 ANTIBODIES.....................................................................................................................204 TROPOMYOSIN 5 ANTIBODIES..................................................................................................... 205 TRYPTOPHAN HYDROXYLASE (TPH) ANTIBODIES .......................................................................... 205 TSH RECEPTOR ANTIBODIES (TRAB)..........................................................................................206 TYROSINASE ANTIBODIES........................................................................................................... 208 TYROSINE HYDROXYLASE (TH) ANTIBODIES...................................................................................208 VASOPRESSIN PRODUCING CELL ANTIBODIES..................................................................................208 VGCC ANTIBODIES....................................................................................................................209 VGPC ANTIBODIES...................................................................................................................209 WARM ANTIBODIES....................................................................................................................209 VON WILLEBRAND FACTOR ANTIBODIES.......................................................................................210 XANCA................................................................................................................................... 210 YO ANTIBODIES........................................................................................................................ 210 ZIC ANTIBODIES........................................................................................................................ 212 ZNT8 ANTIBODIES.................................................................................................................... 212 PART 2 ORGAN SPECIFIC AUTOIMMUNE DISEASES - SYMPTOMS, ENTITIES, SYNDROMES ACHALASIA.............................................................................................................................. 216 ACQUIRED ANGIOEDEMA TYPE II................................................................................................216 ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)..................................................................216 ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY (AIDP)..................................................217 ACUTE MOTOR AXONAL NEUROPATHY (AMAN).............................................................................. 217 ACUTE MOTOR SENSORY AXONAL NEUROPATHY (AMSAN)..............................................................217 ACUTE PANDYSAUTONOMIA.......................................................................................................217 ADDISONS DISEASE................................................................................................................. 218 ADENOHYPOPHYSITIS................................................................................................................ 218 ADRENOCORTICAL INSUFFICIENCY..................................................................................................219 ALH-PBC-OVERLAP SYNDROME.................................................................................................219 AIH-PSC OVERLAP SYNDROME..................................................................................................220 ALKALINE PHOSPHATASE INCREASE..............................................................................................220 ALOPECIA AREATA..................................................................................................................... 220 AMINOTRANSFERASE INCREASE...................................................................................................221 ANEMIA...................................................................................................................................221 ANGIOEDEMA.......................................................................................................................... 222 ANTI-GBM NEPHRITIS................................................................................................................ 223 ANTI-NMDA RECEPTOR ENCEPHALITIS......................................................................................... 224 APLASTIC ANEMIA..................................................................................................... 224 ARTHROGRYPOSIS MULTIPLEX CONGENITAL (AMC).......................................................................... 225 ATAXIA.....................................................................................................................................225 AUTOIMMUNE ADRENALITIS........................................................................................................226 AUTOIMMUNE AUTONOMIC GANGLIOPATHY (AAG)....................................................................... 226 AUTOIMMUNE BLISTERING DISEASES...........................................................................................227 AUTOIMMUNE CHOLANGITIS (AIC)..............................................................................................228 AUTOIMMUNE CYTOPENIA.........................................................................................................228 AUTOIMMUNE ENTEROPATHY (AIE)............................................................................................228 AUTOIMMUNE GASTRITIS............................................................................................................ 229 AUTOIMMUNE GASTROINTESTINAL DYSMOTILITY (AIGD).................................................................. 231 AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) ................................................................................ 232 AUTOIMMUNE HEMOPHILIA.......................................................................................................232 AUTOIMMUNE HEPATITIS (AIH)..................................................................................................233 AUTOIMMUNE HEPATITIS (AIH) TYPE 1 .......................................................................................236 AUTOIMMUNE HEPATITIS (AIH) TYPE 2 .......................................................................................237 AUTOIMMUNE HEPATITIS (AIH) TYPE 3 .......................................................................................237 AUTOIMMUNE HYPERPARATHYROIDISM........................................................................................237 AUTOIMMUNE HYPERTHYROIDISM............................................................................................... 238 AUTOIMMUNE HYPOPARATHYROIDISM.........................................................................................239 AUTOIMMUNE HYPOPHYSITIS..................................................................................................... 239 AUTOIMMUNE LIVER DISEASE..................................................................................................... 241 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS)............................................................ 241 AUTOIMMUNE NEUROPATHY....................................................................................................... 242 AUTOIMMUNE NEUTROPENIA...................................................................................................... 243 AUTOIMMUNE PANCREATITIS (AIP)............................................................................................. 244 AUTOIMMUNE PANCREATOCHOLANGITIS (AIPC)............................................................................246 AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY SYNDROME (APECED) ................................................................................................................................................246 AUTOIMMUNE POLYGLANDULAR SYNDROME (APS) ....................................................................... 246 AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 1 (APS-1)......................................................... 246 AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2 (APS-2)......................................................... 248 AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 3 (APS-3)......................................................... 249 AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (PAP) .......................................................... 249 AUTOIMMUNE SCLEROSING CHOLANGITIS (ASC)............................................................................250 AUTOIMMUNE THROMBOCYTOPENIA (AITP).................................................................................251 AUTOIMMUNE THYROIDITIS (AIT)................................................................................................ 251 AUTOIMMUNE THYROPATHIES (AITP).......................................................................................... 253 AUTOIMMUNE URTICARIA.............................................................................................................253 BICKERSTAFFS ENCEPHALITIS...................................................................................................... 254 BLISTERING DERMATOSES............................................................................................................254 BRAINSTEM ENCEPHALITIS.......................................................................................................... 255 BULLOUS PEMPHIGOID...............................................................................................................255 CANOMAD SYNDROME............................................................................................................256 CAR SYNDROME......................................................................................................................256 CEC SYNDROME......................................................................................................................257 CELIAC DISEASE.......................................................................................................................257 CEREBELLAR ATAXIA....................................................................................................................262 CEREBRAL FOLATE DEFICIENCY SYNDROME....................................................................................262 CHAGAS CARDIOMYOPATHY....................................................................................................... 263 CHOLANGIOPATHIES...................................................................................................................263 CHRONIC ATROPHIC GASTRITIS...................................................................................................... 263 CHRONIC GASTROINTESTINAL PSEUDO-OBSTRUCTION ........................................................................ 264 CHRONIC HEPATITIS....................................................................................................................264 CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)..............................................265 CHRONIC NON-PURULENT DESTRUCTIVE CHOLANGITIS....................................................................... 266 CHRONIC SENSORY ATAXIC NEUROPATHY WITH ANTI-DISIALOSYL ANTIBODIES ..................................... 266 COGAN SYNDROME.................................................................................................................. 266 COLLAGENOUS CELIAC DISEASE..................................................................................................267 COLLAGENOUS COLITIS................................................................................................................ 267 COMPLEX REGIONAL PAIN SYNDROME (CRPS)........................................................................... 267 CROHNS DISEASE..................................................................................................................... 268 CRYPTOGENIC HEPATITIS............................................................................................................ 269 CRYPTOGENIC LIVER CIRRHOSIS.....................................................................................................269 DERMATITIS HERPETIFORMIS (DH)...............................................................................................270 DIABETES INSIPIDUS................................................................................................................. 271 DIABETES MELLITUS TYPE 1........................................................................................................ 271 DIABETES MELLITUS TYPE 3........................................................................................................273 DILATED CARDIOMYOPATHY........................................................................................................ 273 DOWN SYNDROME.................................................................................................................... 274 DRUG INDUCED (AUTOIMMUNE) HEPATITIS .................................................................................. 274 ENCEPHALITIS...........................................................................................................................275 ENCEPHALOMYELITIS................................................................................................................. 275 ENDEMIC PEMPHIGUS FOLIACEUS..............................................................................................276 ENDOCRINE ORBITOPATHY........................................................................................................... 277 ENDOMETRIOSIS....................................................................................................................... 278 EPIDERMOLYSIS BULLOSA ACQUISITA............................................................................................278 EPILEPSY.................................................................................................................................279 EVANS SYNDROME................................................................................................................... 280 FUNICULAR MYELOSIS................................................................................................................ 280 GAMMA GLUTAMYLTRANSFERASE (YGT) ELEVATION...................................................................... 281 GLOMERULONEPHRITIS................................................................................................................ 281 GLUTEN ATAXIA......................................................................................................................... 282 GLUTEN SENSITIVE ENTEROPATHY................................................................................................283 GOITER.....................................................................................................................................283 GOODPASTURE SYNDROME........................................................................................................ 283 GRAVES* DISEASE.................................................................................................................... 284 GUILLAIN-BARRE SYNDROME (GBS)............................................................................................284 HASHIMOTOS ENCEPHALITIS......................................................................................................285 HASHIMOTOS THYROIDITIS.......................................................................................................... 286 HEMOLYTIC UREMIC SYNDROME (HUS) ..................................................................................... 286 HEPARIN INDUCED THROMBOCYTOPENIA (HIT)............................................................................ 287 HYPERTHYROIDISM.................................................................................................................... 287 HYPOCOMPLEMENTEMIC URTICARIA-VASCULITIS SYNDROME (HUVS)..............................................288 HYPOGONADISM...................................................................................................................... 289 HYPOPITUITARISM..................................................................................................................... 289 HYPOTHYROIDISM......................................................................................................................290 IDIOPATHIC LYMPHADENOPATHY................................................................................................. 291 IGA NEPHROPATHY....................................................................................................................291 IMMUNE CHOLANGIOPATHY........................................................................................................ 292 IMMUNOGLOBULIN G4 ASSOCIATED CHOLANGITIS (IAC) ................................................................ 292 IMMUNOGLOBULIN G4 ASSOCIATED SCLEROSING DISEASE ............................................................. 292 INDETERMINATE COLITIS...............................................................................................................293 INFLAMMATORY BOWEL DISEASE (IBD)........................................................................................ 294 INFUNDIBULONEUROHYPOPHYSITIS............................................................................................... 294 INSULIN AUTOIMMUNE SYNDROME (IAS).....................................................................................295 INSULIN RESISTANCE TYPE B ....................................................................................................... 295 INTERSTITIAL PNEUMONIA.............................................................................................................296 IPEX SYNDROME......................................................................................................................296 KUETTNER TUMORS....................................................................................................................... 297 LADA..................................................................................................................................... 297 LAMBERT-EATON MYASTHENIC SYNDROME (LEMS) .................................................................... 298 LICHEN RUBER PEMPHIGOIDES.................................................................................................. 298 LIMBIC ENCEPHALITIS................................................................................................................299 LINEAR IGA DERMATOSIS (LAD)................................................................................................ 300 LIVER CIRRHOSIS......................................................................................................................... 301 LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS (LE IM ) .......................................................... 301 LYMPHOCYTIC COLITIS.................................................................................................................301 LYMPHOCYTIC GASTRITIS.............................................................................................................301 MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) ............................................................. 302 MEMBRANOUS GLOMERULONEPHRITIS.......................................................................................... 303 MICROSCOPIC COLITIS..................................................................................................................303 MIKULICZ SYNDROME.................................................................................................................304 MILLER FISHER SYNDROME (M FS).............................................................................................. 304 MINIMAL CHANGE GLOMERULONEPHRITIS......................................................................................305 MONOGENIC AUTOIMMUNE DISEASES........................................................................................ 305 MORVANS SYNDROME...............................................................................................................306 MOTOR NEUROPATHY WITH MONOCLONAL IGM GAMMOPATHY ......................................................... 306 MUCOUS MEMBRANE PEMPHIGOID............................................................................................ 306 MULTIFOCAL ACQUIRED DEMYELINATING SENSORIMOTOR NEUROPATHY (MADSAM) ........................... 307 MULTIFOCAL MOTOR NEUROPATHY (MMN).....................................................................................308 MULTIPLE SCLEROSIS...................................................................................................................308 MYASTHENIA GRAVIS..................................................................................................................309 NARCOLEPSY............................................................................................................................. 311 NEUROMYELITIS OPTICA (NMO).................................................................................................. 312 NEUROMYOTONIA......................................................................................................................314 NEUROPATHIES WITH ANTI-SULFATIDE ANTIBODIES..........................................................................314 OPSOCLONUS MYOCLONUS SYNDROME (OMS) ........................................................................... 315 OPTIC NEURITIS..........................................................................................................................315 ORDS THYROIDITIS......................................................................................................................316 ORMONDS DISEASE................................................................................................................. 316 OSTEOPOROSIS..........................................................................................................................316 OVARIAN INSUFFICIENCY............................................................................................................. 317 OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES.............................................................. 317 PANDAS................................................................................................................................318 PARANEOPLASTIC AUTONOMIC NEUROPATHIES .............................................................................. 319 PARANEOPLASTIC CEREBELLAR DEGENERATION (PCD)................................................................... 319 PARANEOPLASTIC DISEASES (SYNDROMES) ................................................................................. 320 PARANEOPLASTIC ENCEPHALOMYELITIS (PEM) ............................................................................ 320 PARANEOPLASTIC NEUROLOGICAL DISEASES ................................................................................. 321 PARANEOPLASTIC PEMPHIGUS................................................................................................... 323 PARANEOPLASTIC RETINOPATHY................................................................................................... 323 PARAPROTEINEMIC DEMYELINATING NEUROPATHIES ...................................................................... 324 PARTIAL LIPODYSTROPHY............................................................................................................. 324 PEMPHIGOID............................................................................................................................325 PEMPHIGOID GESTATIONIS......................................................................................................... 325 PEMPHIGUS.............................................................................................................................326 PEMPHIGUS FOLIACEUS............................................................................................................. 326 PEMPHIGUS HERPETIFORMIS...................................................................................................... 327 PEMPHIGUS VULGARIS.............................................................................................................. 327 PERM.................................................................................................................................... 328 PERNICIOUS ANEMIA................................................................................................................ 328 POLYNEUROPATHY (PNP).......................................................................................................... 329 PORTAL HYPERTENSION............................................................................................................... 330 POSTINFECTIOUS (AUTOIMMUNE) HEPATITIS ................................................................................. 330 POSTPARTUM HEPATITIS............................................................................................................. 331 POSTPARTUM THYROIDITIS........................................................................................................... 331 POSTTRANSPLANT NEPHRITIS........................................................................................................ 332 POSTURAL TACHYCARDIA SYNDROME (POTS) .............................................................................. 332 PREECLAMPSIA.........................................................................................................................333 PREMATURE OVARIAN INSUFFICIENCY............................................................................................334 PRIMARY BILIARY CHOLANGITIS (PBC)..........................................................................................334 PRIMARY MYXEDEMA............................................................................................................... 337 PRIMARY SCLEROSING CHOLANGITIS (PSC)....................................................................................337 PRURITUS..................................................................................................................................339 PULMORENAL SYNDROME........................................................................................................... 339 RAPID-PROGRESSIVE GLOMERULONEPHRITIS (RPGN).................................................................... 339 RASMUSSENS ENCEPHALITIS.................................................................................................... 340 RETROPERITONEAL FIBROSIS..........................................................................................................340 RIEDELS THYROIDITIS..................................................................................................................341 SCLEROSING CHOLANGITIS (SC)................................................................................................... 341 SCLEROSING SIALADENITIS...........................................................................................................341 SENSORINEURAL HEARING LOSS................................................................................................... 341 SICCA SYMPTOMS.....................................................................................................................342 STIFF PERSON SYNDROME (SPS)................................................................................................ 342 SUBACUTE CEREBELLAR DEGENERATION........................................................................................ 343 SUBACUTE SENSORY NEUROPATHY (SSN)...................................................................................343 SUDECKS DISEASE...................................................................................................................344 SYDENHAM CHOREA..................................................................................................................344 SYMPATHETIC OPHTHALMIA....................................................................................................... 345 THROMBOTIC MICROANGIOPATHY................................................................................................ 345 THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP).......................................................................345 TRANSVERSE MYELITIS................................................................................................................346 TUBULOINTERSTITIAL NEPHRITIS......................................................................................................346 ULCERATIVE COLITIS..................................................................................................................... 346 VITILIGO.................................................................................................................................... 348
any_adam_object	1
author	Conrad, Karsten 1956- Schößler, Werner Hiepe, Falk Fritzler, Marvin J.
author_GND	(DE-588)110452917 (DE-588)1165012626 (DE-588)109617266 (DE-588)1165020831
author_facet	Conrad, Karsten 1956- Schößler, Werner Hiepe, Falk Fritzler, Marvin J.
author_role	aut aut aut aut
author_sort	Conrad, Karsten 1956-
author_variant	k c kc w s ws f h fh m j f mj mjf
building	Verbundindex
bvnumber	BV045125307
classification_rvk	XG 4414
classification_tum	MED 330f
ctrlnum	(OCoLC)1043879941 (DE-599)DNB1144662133
discipline	Medizin
edition	second edition
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02502nam a2200517 cb4500</leader><controlfield tag="001">BV045125307</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20181015 </controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">180808s2017 xx a\|\|\| \|\|\|\| 00\|\|\| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1144662133</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783958533486</subfield><subfield code="c">Broschur</subfield><subfield code="9">978-3-95853-348-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1043879941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1144662133</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XG 4414</subfield><subfield code="0">(DE-625)152802:12920</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WD 301</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 330f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Conrad, Karsten</subfield><subfield code="d">1956-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)110452917</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Autoantibodies in organ specific autoimmune diseases</subfield><subfield code="b">a diagnostic reference</subfield><subfield code="c">Karsten Conrad, Werner Schößler, Falk Hiepe, Marvin J. Fritzler</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Lengerich ; Berlin ; Bremen ; Miami ; Riga ; Viernheim ; Wien ; Zagreb</subfield><subfield code="b">Pabst Science Publishers</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 348 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Autoantigens, autoantibodies, autoimmunity</subfield><subfield code="v">Volume 8</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Autoaggressionskrankheit</subfield><subfield code="0">(DE-588)4003935-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Serodiagnostik</subfield><subfield code="0">(DE-588)4181044-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Autoantikörper</subfield><subfield code="0">(DE-588)4215429-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4066724-8</subfield><subfield code="a">Wörterbuch</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Autoaggressionskrankheit</subfield><subfield code="0">(DE-588)4003935-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Serodiagnostik</subfield><subfield code="0">(DE-588)4181044-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Autoantikörper</subfield><subfield code="0">(DE-588)4215429-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schößler, Werner</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1165012626</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hiepe, Falk</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)109617266</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fritzler, Marvin J.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1165020831</subfield><subfield code="4">aut</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Gesellschaft zur Förderung der Immundiagnostik</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)10091100-6</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, eBook</subfield><subfield code="z">978-3-95853-349-3</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Autoantigens, autoantibodies, autoimmunity</subfield><subfield code="v">Volume 8</subfield><subfield code="w">(DE-604)BV014013293</subfield><subfield code="9">8</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://digitale-objekte.hbz-nrw.de/storage2/2018/03/05/file_19/7577842.pdf</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030515413&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030515413</subfield></datafield></record></collection>
genre	(DE-588)4066724-8 Wörterbuch gnd-content
genre_facet	Wörterbuch
id	DE-604.BV045125307
illustrated	Illustrated
indexdate	2024-12-20T18:18:44Z
institution	BVB
institution_GND	(DE-588)10091100-6
isbn	9783958533486
language	German
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-030515413
oclc_num	1043879941
open_access_boolean
owner	DE-578 DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-91 DE-BY-TUM
owner_facet	DE-578 DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-91 DE-BY-TUM
physical	XVI, 348 Seiten Illustrationen
publishDate	2017
publishDateSearch	2017
publishDateSort	2017
publisher	Pabst Science Publishers
record_format	marc
series	Autoantigens, autoantibodies, autoimmunity
series2	Autoantigens, autoantibodies, autoimmunity
spellingShingle	Conrad, Karsten 1956- Schößler, Werner Hiepe, Falk Fritzler, Marvin J. Autoantibodies in organ specific autoimmune diseases a diagnostic reference Autoantigens, autoantibodies, autoimmunity Autoaggressionskrankheit (DE-588)4003935-3 gnd Serodiagnostik (DE-588)4181044-2 gnd Autoantikörper (DE-588)4215429-7 gnd
subject_GND	(DE-588)4003935-3 (DE-588)4181044-2 (DE-588)4215429-7 (DE-588)4066724-8
title	Autoantibodies in organ specific autoimmune diseases a diagnostic reference
title_auth	Autoantibodies in organ specific autoimmune diseases a diagnostic reference
title_exact_search	Autoantibodies in organ specific autoimmune diseases a diagnostic reference
title_full	Autoantibodies in organ specific autoimmune diseases a diagnostic reference Karsten Conrad, Werner Schößler, Falk Hiepe, Marvin J. Fritzler
title_fullStr	Autoantibodies in organ specific autoimmune diseases a diagnostic reference Karsten Conrad, Werner Schößler, Falk Hiepe, Marvin J. Fritzler
title_full_unstemmed	Autoantibodies in organ specific autoimmune diseases a diagnostic reference Karsten Conrad, Werner Schößler, Falk Hiepe, Marvin J. Fritzler
title_short	Autoantibodies in organ specific autoimmune diseases
title_sort	autoantibodies in organ specific autoimmune diseases a diagnostic reference
title_sub	a diagnostic reference
topic	Autoaggressionskrankheit (DE-588)4003935-3 gnd Serodiagnostik (DE-588)4181044-2 gnd Autoantikörper (DE-588)4215429-7 gnd
topic_facet	Autoaggressionskrankheit Serodiagnostik Autoantikörper Wörterbuch
url	http://digitale-objekte.hbz-nrw.de/storage2/2018/03/05/file_19/7577842.pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030515413&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link	(DE-604)BV014013293
work_keys_str_mv	AT conradkarsten autoantibodiesinorganspecificautoimmunediseasesadiagnosticreference AT schoßlerwerner autoantibodiesinorganspecificautoimmunediseasesadiagnosticreference AT hiepefalk autoantibodiesinorganspecificautoimmunediseasesadiagnosticreference AT fritzlermarvinj autoantibodiesinorganspecificautoimmunediseasesadiagnosticreference AT gesellschaftzurforderungderimmundiagnostik autoantibodiesinorganspecificautoimmunediseasesadiagnosticreference

Verfügbarkeit

Bestellen (Login erforderlich)

Inhaltsverzeichnis
Paper/Kapitel scannen lassen

Teilbibliothek Medizin

Bestandsangaben von Teilbibliothek Medizin
Signatur:	1102 MED 330f 2018 A 4647(2) Lageplan
Exemplar 1	Ausleihbar Am Standort